DIGNITANA
Sweden - LundBiotechnology
Focus: DIGNITANA develops a scalp cooling device designed to minimize hair loss in cancer patients undergoing chemotherapy, addressing a significant quality-of-life concern in oncology. The company is publicly traded and operates from Lund, Sweden as a focused medical device biotech.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About DIGNITANA
AI assessmentNot HiringNo open roles listed right now. Follow DIGNITANA to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Scalp Cooling Device
Stable
Growth
Core proprietary device addressing a significant quality-of-life burden in oncology with potential for expanded clinical adoption and reimbursement.
Open Jobs (0)
Help build intelligence for DIGNITANA
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.